One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Compelling Story of Ovarian Cancer Screening.
Pavlik, Edward J. PhD 1; van Nagell, John R. Jr MD 1; Dietrich, Charles S. III MD 1; Ueland, Frederick R. MD 1,
doi : 10.1200/JCO.23.02424
Volume 42(10) pgs. 1091-1206 April 1, 2024
Delaying Prostate-Specific Antigen Progression in Biochemically Recurrent Prostate Cancer: Is It Clinically Meaningful?.
Childs, Daniel S. MD 1,,; Orme, Jacob J. MD, PhD 1,; Ravi, Praful MB, MRCP, BChir 2,
doi : 10.1200/JCO.23.02410
Emerging Role of Liver Transplantation for Unresectable Colorectal Liver Metastases.
Chavez-Villa, Mariana MD 1; Ruffolo, Luis I. MD 1; Line, Pal-Dag MD, PhD 2,3; Dueland, Svein MD, PhD 2,4; Tomiyama, Koji MD, PhD 1; Hernandez-Alejandro, Roberto MD 1,
doi : 10.1200/JCO.23.01781
Normal Risk Ovarian Screening Study: 21-Year Update.
Han, Chae Young PhD 1; Lu, Karen H. MD 2; Corrigan, Gwen BSN 1,; Perez, Alexandra CMA 1; Kohring, Sharlene D. HSD 1,; Celestino, Joseph BS 2; Bedi, Deepak MD 3; Bedia, Enrique MD 4; Bevers, Therese MD 5,; Boruta, David MD 2; Carlson, Matthew MD 6; Holman, Laura MD 7,; Leeds, Leroy MD 8,+; Mathews, Cara MD 9,; McCann, Georgia MD 10; Moore, Richard G. MD 11,; Schlumbrecht, Matthew MD 12,; Slomovitz, Brian MD 12,13,; Tobias, Dan MD 13,; Williams-Brown, Yvette MD 14; Bevers, Michael W. MD 2; Liu, Jinsong MD 15; Gornet, Terrie G. BS 15; Handy, Beverly C. MD 15,; Lu, Zhen MD 1,; Bedia, Jacob S. BS 16; Skates, Steven J. PhD 16,; Bast, Robert C. Jr MD 1,,
doi : 10.1200/JCO.23.00141
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer.
Stinchcombe, Thomas E. MD 1,,; Wang, Xiaofei PhD 2; Damman, Bryce MS 3; Mentlick, Jennifer HS 3,; Landreneau, Rodney MD 4; Wigle, Dennis MD, PhD 5,; Jones, David R. MD 6,; Conti, Massimo MD 7; Ashrafi, Ahmad S. MD 8,; Liberman, Moishe MD, PhD 9,; de Perrot, Marc MD 10,; Mitchell, John D. MD 11,; Keenan, Robert MD 12; Bauer, Thomas MD 13; Miller, Daniel MD 14,; Altorki, Nasser MD 15,
doi : 10.1200/JCO.23.01306
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19).
Aggarwal, Rahul MD 1,,; Heller, Glenn PhD 2; Hillman, David W. MS 3; Xiao, Han MD 2; Picus, Joel MD 4,; Taplin, Mary-Ellen MD 5,; Dorff, Tanya MD 6,; Appleman, Leonard MD 7,; Weckstein, Douglas MD 8; Patnaik, Akash MD 9,; Bryce, Alan MD 10,; Shevrin, Daniel MD 11; Mohler, James MD 12,; Anderson, Daniel MD 13; Rao, Arpit MD 14,; Tagawa, Scott MD 15,; Tan, Alan MD 16,; Halabi, Susan PhD 17,; Dooley, Katharine MPH 3; O'Brien, Patrick BS 3,; Chen, Ronald MD, MPH 18,; Ryan, Charles J. MD 19; Eggener, Scott E. MD 9,; Morris, Michael J. MD 2,; Aggarwal, Rahul; Shevrin, Daniel; Tagawa, Scott; Kim, Charles; Taplin, Mary-Ellen; Whang, Young; Dakhil, Shaker; Smith, Raymond; Gartrell, Benjamin; Fagbemi, Seth; Mowat, Rex; Farber, Charles; Hashemi, Neda; Humeniuk, Michael; Ryan, Charles; Ellerton, John; Olsen, Mark; Wang, Jennifer; Dorff, Tanya; Karina Pascual, Sheila; Weckstein, Douglas; Weckstein, Douglas; Bryce, Alan; Mohler, James; Michael Randall, James; Xiao, Han; Patnaik, Akash; King, David; Picus, Joel; Kilari, Deepak; Monk, Paul; Bitting, Rhonda; Appleman, Leonard; Eugenio Najera, Jose; Rowland, Kendrith; Hauke, Ralph; Shehadeh, Nasfat; Curti, Brendan; Gupta, Gopal; Tan, Alan; Collins, Timothy; Beer, Tomasz; Tate, David; Sheh, Bryant; Basnet, Alina; Conway, James; Gross, Howard; Goodman, Michael
doi : 10.1200/JCO.23.01157
Locoregional Breast Cancer Recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: Analysis of Risk Factors Including the 70-Gene Signature.
Alaeikhanehshir, Sena MD 1,2,; Ajayi, Taiwo MSc 3; Duijnhoven, Frederieke H. MD, PhD 2; Poncet, Coralie MSc 3; Olaniran, Ridwan O. PhD 3; Lips, Esther H. PhD 1; van 't Veer, Laura J. PhD 4,; Delaloge, Suzette MD, MSc 5,; Rubio, Isabel T. MD, PhD 6,; Thompson, Alastair M. MD, FACS 7,; Cardoso, Fatima MD, PhD 8,; Piccart, Martine MD, PhD 9,; Rutgers, Emiel J.T. MD, PhD 2,
doi : 10.1200/JCO.22.02690
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.
Moreno, Lucas MD, PhD 1,,; Weston, Rebekah MSc 2; Owens, Cormac MD 3,; Valteau-Couanet, Dominique MD 4,; Gambart, Marion MD 5; Castel, Victoria MD, PhD 6; Zwaan, C. Michel MD, PhD 7,; Nysom, Karsten MD, PhD 8,; Gerber, Nicolas MD 9; Castellano, Aurora MD 10; Laureys, Genevieve MD, PhD 11; Ladenstein, Ruth MD, PhD 12,; Rossler, Jochen MD 13,; Makin, Guy MD 14; Murphy, Dermot MD 15; Morland, Bruce MD 16; Vaidya, Sucheta MD 17,; Thebaud, Estelle MD 18; van Eijkelenburg, Natasha MD, PhD 7; Tweddle, Deborah A. MD, PhD 19,; Barone, Giuseppe MD, PhD 20,; Tandonnet, Julie MD 21; Corradini, Nadege MD 22; Chastagner, Pascal MD, PhD 23; Paillard, Catherine MD 24; Bautista, Francisco J. MD, PhD 7; Gallego Melcon, Soledad MD, PhD 1; De Wilde, Bram MD, PhD 11; Marshall, Lynley PhD, MB, BCH 17,; Gray, Juliet MD, PhD 25,; Burchill, Susan A. PhD 26; Schleiermacher, Gudrun MD, PhD 27,; Chesler, Louis MD, PhD 17; Peet, Andrew MD, PhD 16; Leach, Martin O. PhD 17; McHugh, Kieran MD 20; Hayes, Roisin MD 3; Jerome, Neil PhD 17,; Caron, Hubert MD, PhD 28,; Laidler, Jennifer BSc 2; Fenwick, Nicola BSc 2; Holt, Grace MsC 2; Moroz, Veronica MsC 2,; Kearns, Pamela MD, PhD 2,; Gates, Simon PhD 2,; Pearson, Andrew D.J. MD 17,; Wheatley, Keith DPhil 2,; on behalf of Innovative Therapies for Children with Cancer (ITCC) and European Association for Neuroblastoma Research (SIOPEN); Valteau-Couanet, Dominique; Jose Bautista, Francisco; Murphy, Dermot; Makin, Guy; Thebaut, Estelle; van Eijkelenburg, Natasha; Hobin, Dave; Vaidya, Sucheta; Elliott, Martin; Schleiermacher, Gudrun; Owens, Cormac; Barone, Giuseppe; Tweddle, Deborah; Castel, Victoria; Nysom, Karsten; Tandonnet, Julie; Corradini, Nadege; Chastagner, Pascal; Gambart, Marion; Jannier, Sarah; Castellano, Aurora; Gallego, Soledad; Coze, Carole; Auvrignon, Anne; Sophie Defachelles, Anne; Lopez Almaraz, Ricardo; Gerber, Nicolas; Ladenstein, Ruth; De Wilde, Bram; Brichard, Benedicte; Luksch, Roberto; Zwaan, Michel; Popovic Maja, Beck; Willis, Courtney; Gray, Juliet; Hettmer, Simone; Schweigerer, Lothar; Kontny, Udo; Christiansen, Holger; Garaventa, Alberto; Ng, Anthony; Howell, Lisa; Yeomanson, Daniel
doi : 10.1200/JCO.23.00458
Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study.
Wang, Michael MD 1,,; Siddiqi, Tanya MD, MBBS 2,; Gordon, Leo I. MD 3,; Kamdar, Manali MD, MBBS 4,; Lunning, Matthew DO 5,; Hirayama, Alexandre V. MD 6,; Abramson, Jeremy S. MD, MMSc 7,; Arnason, Jon MD 8,; Ghosh, Nilanjan MD, PhD 9,; Mehta, Amitkumar MD 10,; Andreadis, Charalambos MD, MS 11,; Solomon, Scott R. MD 12; Kostic, Ana MD 13,; Dehner, Christine BSc 13,; Espinola, Ricardo MD 14,; Peng, Lily MS 13,; Ogasawara, Ken PhD, MPH 15,; Chattin, Amy PhD 13,; Eliason, Laurie MPH 15,; Palomba, M. Lia MD 16,
doi : 10.1200/JCO.23.02214
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations.
Russell, Nigel H. MD 1,,; Wilhelm-Benartzi, Charlotte PhD 2; Othman, Jad MBBS 3; Dillon, Richard PhD 3,; Knapper, Steven MD 4,; Batten, Leona M. MSc 2; Canham, Joanna PhD 2,; Hinson, Emily L. PhD 2; Betteridge, Sophie PhD 2; Overgaard, Ulrik Malthe MD 5,; Gilkes, Amanda PhD 4; Potter, Nicola PhD 3; Mehta, Priyanka MD 6,; Kottaridis, Panagiotis MD 7; Cavenagh, Jamie MD 8,; Hemmaway, Claire MD 9; Arnold, Claire MD 10,; Freeman, Sylvie D. PhD 11,; Dennis, Mike MD 12,; Kallenbach, Maria; Severinsen, Marianne; Holm, Mette; Maxwell Norgaard, Jan; Beier Ommen, Hans; Culligan, Dominic; Tighe, Jane; Craig, Jenny; Crawley,Â
doi : 10.1200/JCO.23.00943
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator.
Varey, Alexander H.R. MBChB, PhD, FRACS(Plast), FRCS(Plast) 1,,2,3,; Li, Isabel MAppStats, MStats(Res), BActSC 1,2; El Sharouni, Mary-Ann MD, PhD, MSc 4; Simon, Julie MHA 5; Dedeilia, Aikaterini MD 6; Ch'ng, Sydney PhD, MBBS, FRACS, FACS 1,2,7,8; Saw, Robyn P.M. MBBS, MS, FRACS 1,2,7,; Spillane, Andrew J. MD, BM BS, FRACS 1,2,; Shannon, Kerwin F. MBBS, FRACS 1,2,7; Pennington, Thomas E. MBBS, MS, BSc, FRACS(Plast) 1,2,7; Rtshiladze, Michael MBBS, MS, BSc, FRACS(Plast) 1,7,; Stretch, Jonathan R. DPhil, FRACS(Plast) 1,2,7; Nieweg, Omgo E. MD, PhD 1,2,7; van Akkooi, Alexander MD, PhD 1,2,7,; Sullivan, Ryan J. MD 6,; Boland, Genevieve M. MD, PhD 6,; Gershenwald, Jeffrey E. MD, FACS, FAAAS, FRACS(Hon) 5,; van Diest, Paul J. MD, PhD 4,; Scolyer, Richard A. MD, MBBS, BMedSci, FRCPA, FRCPath 1,2,9,10,; Long, Georgina V. PhD, MBBS, BSc, FRACP 1,2,11,9,; Thompson, John F. MD, FRACS, FACS 1,2,7,; Lo, Serigne N. PhD, MSc, MRes, AStat 1,2
doi : 10.1200/JCO.23.01020
Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology.
Shriver, Sharon P. PhD 1,,; Adams, Devon RN, MPH 1,; McKelvey, Brittany Avin PhD 2; McCune, Jeannine S. PharmD, PhD 3,; Miles, Dale PhD 4,; Pratt, Victoria M. PhD, FACMG 5,; Ashcraft, Kristine MBA 6,7,; McLeod, Howard L. PharmD 8,; Williams, Hannah MPH 9,; Fleury, Mark E. PhD 1,
doi : 10.1200/JCO.23.01748
US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer.
Shah, Mirat MD 1,; Lingam, Hima MD 1; Gao, Xin PhD 1; Gittleman, Haley PhD 1; Fiero, Mallorie H. PhD 1; Krol, Danielle MD 1; Biel, Nikolett PhD 1; Ricks, Tiffany K. PhD 1; Fu, Wentao PhD 1,; Hamed, Salaheldin PhD 1,; Li, Fang PhD 1; Sun, Jillian (Jielin) PhD 1; Fan, Jianghong PhD 1; Schuck, Robert PharmD, PhD 1; Grimstein, Manuela PhD 1,; Tang, Liuya PhD 2; Kalavar, Shyam PhD 2; Abukhdeir, Abdelrahmman PhD 2,; Pathak, Anand MD, PhD, MPH 2; Ghosh, Soma PhD 2; Bulatao, Ilynn MD, PhD 3; Tilley, Amy BBA 1; Pierce, William F. PharmD, MPH 3; Mixter, Bronwyn D. 3; Tang, Shenghui PhD 1; Pazdur, Richard MD 1,3; Kluetz, Paul MD 1,3; Amiri-Kordestani, Laleh MD 1,3
doi : 10.1200/JCO.23.02112
Interpretation of the EORTC-55954 Trial: Does the Response to Neoadjuvant Chemotherapy Have an Effect on Disease Outcome?.
Mutlu Sutcuoglu, Bengu MD; Sutcuoglu, Osman MD
doi : 10.1200/JCO.23.01988
Reply to B. Mutlu Sutcuoglu et al.
Kenter, Gemma MD, PhD; Greggi, Stefano MD, PhD; Vergote, Ignace MD, PhD; Coens, Corneel PhD; Casado, Antonio MD, PhD
doi : 10.1200/JCO.23.02390
